Pioneer of the Month: Ronald Lawrence Shapiro, MD

David Sinclair is criticized for being more business-oriented than scientific, with accusations of fraud and unethical practices. There is skepticism about his claims on baldness reversal, despite some acknowledging his achievements in gene therapy.

Hair loss treatments discussed include Minoxidil, finasteride, and RU58841. There is skepticism about claims of a breakthrough, despite FDA approval for human trials.

The conversation discusses patient updates on hair loss treatment with Verteporfin after five months, as reported by Dr. Blake Bloxham. Patients voluntarily sent their progress pictures to Dr. Bloxham.

The conversation humorously discusses the fictional "Post PP405 Syndrome" and the idea of starting a foundation or cult around it. It mentions skepticism about the effectiveness of PP405 and jokes about future therapies.

A 21-year-old has been using daily oral finasteride, minoxidil, biotin, and vitamins since January 2026 for hair loss, adding topical treatments and microneedling in May. They observed initial shedding and scalp issues but noted significant progress after adjusting their routine.

Shiseido RCH-01 and Replicel's upcoming trial data release. Users discuss expected release timelines and clarify quarter dates.